期刊文献+

利拉鲁肽对缺氧/复氧诱导的乳鼠心肌细胞损伤的影响

Effects of Liraglutide on the Injury of Neonatal Rat Cardiomyocytes Induced by Hypoxia / Reoxygenation
下载PDF
导出
摘要 【目的】观察新型降糖药物利拉鲁肽对缺氧/复氧(H/R)诱导的乳鼠心肌细胞损伤的影响。【方法】将体外培养Wistar大鼠乳鼠心肌细胞进行分组:单纯H/R组(A组)、利拉鲁肽组+H/R组(B组)、正常对照组(C组),将A,B两组细胞同时进行H/R损伤,复氧后分别检测3组的乳酸脱氢酶(LDH)、丙二醛含量(MDA)、超氧化酶歧化酶(SOD)活性及各组心肌细胞凋亡率。【结果】A组与C组比较,其细胞培养液中LDH、MDA含量、细胞凋亡率均增加,SOD活性降低,且差异有显著性(P〈0.01)。与A组相比,B组LDH、MDA含量、细胞凋亡率则明显降低(P〈0.01),但仍高于C组,且差异有显著性(P〈0.01);SOD活性较A组增高,差异亦有显著性(P〈0.01)。【结论】H/R可以造成心肌细胞的损伤,增加细胞的凋亡;利拉鲁肽作为胰高血糖素样肽-1类似物,其直接作用于心肌细胞,可减轻H/R造成的心肌细胞损伤,抑制心肌细胞的凋亡,具有潜在的心脏保护作用。 [Objective]To observe the effects of a new antidiabetic drug Liraglutide on injury of neonatal rat cardiomyocytes induced by hypoxia / reoxygenation(H/R).[Method] Wistar rat myocardial cells were cultured in vitro and were divided into three groups., simple H/R group(group A ), Liraglutide + H/R group (group B ), and normal control group (group C). In addition to the normal control group, the remaining two groups were injured by H/R. Dehydrogenase (LDH), malondialdehyde (MDA) levels, superoxide dismutase (SOD) activity, and apoptotic Cardiomyocytes were detected in the three groups. [Results]Compared with group C, MDA, LDH levels, and apoptosis rate in group A were significantly higher, and the activity of SOD was lower ( P 〈0.01). Compared with group A, the LD H, MDA level, and cell apoptosis rate in group B was significantly lower ( P 〈0.01), but was still higher than those in group C ( P 〈0.01). Compared with groups B and C, the SOD activity was significantly higher in group A ( P 〈0.01). [Conclusion]H/R can damage of myocardial cells and increase cell apoptosis. As glucagon like peptide-1 analogue, Liraglutide shows potential cardioprotective effects by directly acting on myocardial cells, which includes reducing myocardial cell injury and inhibiting the apoptosis caused by H/R.
出处 《医学临床研究》 CAS 2016年第12期2346-2348,共3页 Journal of Clinical Research
关键词 降血糖药/治疗应用 肌细胞 心脏 缺氧 创伤和损伤 细胞凋亡 Hypoglyeemic Agents/TU Myoeytes, Cardiac Anoxia Wounds and Injuries Apoptosis
  • 相关文献

参考文献3

二级参考文献107

  • 1Juutilainen A, Lehto S, Ronnemaa T, et al. Type 2 diabetes as a "coronary heart disease equivalent" : an 18-year prospective population- based study in Finnish subjects. Diabetes Care, 2005,28:2901-2907. 被引量:1
  • 2Haffner S M, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med, 1998,339:229- 234. 被引量:1
  • 3Richter G, Feddersen O, Wagner U, et al. GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery. Am J Physiol, 1993,265 (4 Pt 1 ) :L374-L381. 被引量:1
  • 4Ishibashi Y, Matsui T, Takeuchi M, et al. Glucagon-like peptide-1 ( GLP-1 ) inhibits advanced glycation end product ( AGE ) -induced up- regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor ( RAGE ) expression. Biochem Biophys Res Commun, 2010,391 : 1405-1408. 被引量:1
  • 5Matsubara M, Kanemoto S, Leshnower BG, et al. Single dose GLP-1-Tf ameliorates myocardial ischemia/reperfusion injury. J Surg Res, 2011, 165:38-45. 被引量:1
  • 6Shiraki A, Oyama J, Komoda H, et al. The glucagon-like peptide 1 analog liraglutide reduces TNF-alpha-induced oxidative stress and inflammation in endothelial cells. Atherosclerosis, 2012, 221 : 375- 382. 被引量:1
  • 7Schisano B, Harte AL, Lois K, et al. GLP-1 analogue, Liraglutide protects human umbilical vein endothelial cells against high glucose induced endoplasmic reticulum stress. Regul Pept, 2012,174 ( 1-3 ) : 46-52. 被引量:1
  • 8Gaspari T, Liu H, Welungoda I, et al. A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model. Diab Vase Dis Res, 2011,8 : 117-124. 被引量:1
  • 9Gaspari T, Welungoda I, Widdop RE, et al. The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE-/- mouse model. Diab Vase Dis Res, 2013,10:353-360. 被引量:1
  • 10Liu J, Liu Y, Chen L, et al. Glucagon-Like Peptide-1 Analog Liraglutide Protects against Diabetic Cardiomyopathy by the Inhibition of the Endoplasmic Reticulum Stress Pathway. J Diabetes Res, 20t3, 2013:630537. 被引量:1

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部